eslicarbazepine acetate has been researched along with Dizziness in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, R; Gama, H; Magalhães, LM; Moreira, J; Soares-da-Silva, P; Vieira, M | 1 |
| Agredano, PM; Bayarri, PG; Bermejo, PE; Campos, D; Falip, M; García-Morales, I; Gil-Nagel, A; Giráldez, BG; Gomariz, EL; González, FJL; Jiménez-Huete, A; Jovel, CE; Navacerrada, FJ; Ojeda, J; Palao, S; Pascual, MRQ; Prior, MJAA; Sáez, AA; Toledano, R | 1 |
| Ben-Menachem, E; Elger, C; Keller, B; Kowacs, PA; Löffler, K; Rocha, JF; Soares-da-Silva, P; Trinka, E | 1 |
| Blum, D; Fiedler-Kelly, J; Grinnell, T; Ludwig, EA; Passarell, JA; Sunkaraneni, S | 1 |
| Delanty, N; Holtkamp, M; McMurray, R; Sales, F; Serratosa, J; Villanueva, V | 1 |
| Alvarez, BM; Baiges, JJ; Bermejo, P; Bertol, V; Bonet, M; Castro-Vilanova, MD; Esteve, P; Galiano, ML; Garcés, M; Giner, P; Hampel, K; López-González, FJ; Massot-Tarrús, A; Mauri, JÁ; Montoya, J; Ojeda, J; Poza, JJ; Quiroga-Subirana, P; Rodríguez-Osorio, X; Rodriguez-Uranga, JJ; Ruiz-Giménez, J; Toledo, M; Tortosa-Conesa, D; Villanueva, V | 1 |
| Fadda, V; Giovannelli, F; Maratea, D; Verrotti, A; Zaccara, G | 1 |
| Holtkamp, M; Kockelmann, E; Lendemans, D; Losch, FP; McMurray, R | 1 |
| Bermejo, P; Bonet, M; Camacho, JL; Campos, D; Galiano, ML; Garcés, M; Giner, P; Gómez-Ibáñez, A; López-González, FJ; Martínez, P; Massot-Tarrús, A; Mauri, JA; Montoya, J; Ojeda, J; Poza, JJ; Rodriguez-Osorio, X; Rodríguez-Uranga, J; Ruiz-Giménez, J; Toledo, M; Vilella, L; Villanueva, V; Zurita, J | 1 |
| Almeida, L; Gil-Nagel, A; Lopes-Lima, J; Maia, J; Soares-da-Silva, P | 1 |
| Almeida, L; Ben-Menachem, E; Gabbai, AA; Hufnagel, A; Maia, J; Soares-da-Silva, P | 1 |
2 review(s) available for eslicarbazepine acetate and Dizziness
| Article | Year |
|---|---|
Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
Topics: Acetamides; Anticonvulsants; Ataxia; Carbamazepine; Dibenzazepines; Diplopia; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lacosamide; Nervous System Diseases; Oxcarbazepine; Randomized Controlled Trials as Topic; Risk Assessment; Sodium Channel Blockers; Treatment Outcome | 2013 |
Eslicarbazepine acetate (aptiom) for epilepsy.
Topics: Animals; Dibenzazepines; Dizziness; Epilepsy; Fatigue; Humans; Prodrugs; Randomized Controlled Trials as Topic | 2014 |
6 trial(s) available for eslicarbazepine acetate and Dizziness
| Article | Year |
|---|---|
Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience.
Topics: Adult; Aged; Anticonvulsants; Dibenzazepines; Dizziness; Drug-Related Side Effects and Adverse Reactions; Humans; Hyponatremia; Marketing; Middle Aged; Seizures; Treatment Outcome | 2021 |
Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.
Topics: Adult; Alanine Transaminase; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsies, Partial; Equivalence Trials as Topic; Fatigue; Female; gamma-Glutamyltransferase; Headache; Humans; Logistic Models; Male; Middle Aged; Nausea; Treatment Outcome; Voltage-Gated Sodium Channel Blockers; Young Adult | 2018 |
Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Headache; Healthy Volunteers; Humans; Hyponatremia; Male; Middle Aged; Models, Biological; Nausea; Seizures; Sodium; Treatment Outcome | 2018 |
[Anticonvulsant add-on therapy with Eslicarbazepine acetate : Results of the EPOS-study in adults in Germany].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Causality; Chemotherapy, Adjuvant; Comorbidity; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Epilepsy; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Prevalence; Quality of Life; Risk Factors; Treatment Outcome; Voltage-Gated Sodium Channel Blockers; Young Adult | 2016 |
Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticonvulsants; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsies, Partial; Female; Headache; Humans; Male; Middle Aged; Nausea; Patient Selection; Placebos; Seizures; Treatment Outcome | 2009 |
Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.
Topics: Adult; Anticonvulsants; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Epilepsies, Partial; Female; Headache; Humans; Male; Middle Aged; Nausea; Seizures; Treatment Outcome | 2010 |
4 other study(ies) available for eslicarbazepine acetate and Dizziness
| Article | Year |
|---|---|
Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Child; Depression; Dibenzazepines; Dizziness; Female; Headache; Humans; Male; Middle Aged; Prospective Studies; Seizures; Spain; Treatment Outcome; Young Adult | 2017 |
Eslicarbazepine acetate as monotherapy in clinical practice: Outcomes from Euro-Esli.
Topics: Adult; Anticonvulsants; Ataxia; Dibenzazepines; Dizziness; Europe; Fatigue; Female; Humans; Male; Middle Aged; Seizures; Sleepiness; Vertigo | 2019 |
MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Dizziness; Epilepsy; Female; Humans; Hyponatremia; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Seizures; Sleepiness; Young Adult | 2019 |
EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure.
Topics: Adult; Aged; Anticonvulsants; Dibenzazepines; Dizziness; Epilepsies, Partial; Female; Humans; Hyponatremia; Male; Middle Aged; Retrospective Studies; Vertigo | 2017 |